Cargando…

Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II

Detalles Bibliográficos
Autores principales:	Patrignani, Paola, Brüne, Bernhard, Steinhilber, Dieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731129/ https://www.ncbi.nlm.nih.gov/pubmed/36506531 http://dx.doi.org/10.3389/fphar.2022.1100420

Ejemplares similares

Editorial: Insights in Inflammation Pharmacology: 2021
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Insights in inflammation pharmacology: 2022
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Eicosanoids in cancer, Volume II
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Women in Inflammation Pharmacology: 2021
por: Patrignani, Paola
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

What Mediates the Inflammation Resolution?
por: Schebb, Nils Helge, et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Streaming inflammation: From damage to healing and resilience–Volume II
por: Devchand, Pallavi R., et al.
Publicado: (2023)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Editorial: Eicosanoids and cytokines: Resolution of inflammation
por: Liu, Jun-Yan
Publicado: (2022)

MicroRNA Involved in Inflammation: Control of Eicosanoid Pathway
por: Ochs, Meike J., et al.
Publicado: (2011)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II
por: Giuliani, Anna Lisa, et al.
Publicado: (2023)

Editorial: Neurobehavioral toxicity induced by environmental contaminants: mechanisms of neurodegeneration and neuroprotection, Volume II
por: Dorta, Daniel J., et al.
Publicado: (2023)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs, Volume II
por: Peluso, Ilaria, et al.
Publicado: (2022)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Editorial: Current Aspects in Chemopreventive Strategies, Volume II
por: Tuli, Hardeep Singh, et al.
Publicado: (2022)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Editorial: Medicinal Cannabis: evolution of therapeutic use, future approaches and other implications, volume II
por: Baratta, Francesca, et al.
Publicado: (2023)

Editorial: Imaging technology in oncology pharmacological research, volume II
por: Zeng, Qi, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II
por: Vaz, Ana Rita, et al.
Publicado: (2023)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

Editorial: Experimental models of epilepsy and related comorbidities, Volume II
por: Shaikh, Mohd Farooq, et al.
Publicado: (2023)

Editorial: Medication safety in COVID-19 management, Volume II
por: Das, Saibal
Publicado: (2023)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Editorial: Liquid biopsy as a tool for precision oncology: New challenges to assess clinical response, Volume II
por: Ulivi, Paola
Publicado: (2023)

Prostanoids and Resolution of Inflammation – Beyond the Lipid-Mediator Class Switch
por: Schmid, Tobias, et al.
Publicado: (2021)

Editorial: Eicosanoids in Cancer
por: Markosyan, Nune, et al.
Publicado: (2021)

Editorial: Toxicity mechanisms, exposure, toxicokinetic and risk assessment aspects of metals, toxic for animals and humans, Volume II
por: Zhu, Yanzhu, et al.
Publicado: (2023)

Editorial: Application of plant secondary metabolites to pain neuromodulation, volume II
por: Singla, Rajeev K., et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: Application of computational tools to health and environmental sciences, Volume II
por: Ruiz, Patricia, et al.
Publicado: (2022)

Editorial: Novel approaches to the treatment of multidrug-resistant bacteria, Volume II
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)
por: Ramírez, Elena, et al.
Publicado: (2023)

Editorial: Model-based evaluation of antimicrobial agents in children—volume II
por: Zhao, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hv41s8s8u6m2bnpcf8aau6g2db